Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo:
This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies–including the use of new clinically-relevant models and imaging technologies–which could lead to first-in-human clinical trials. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk, but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (pre-clinical or clinical).

Inscrições:
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
March 23, 2019.

Mais informações no site.

Objetivo:
The Japanese Society of Psychiatry and Neurology (JSPN) was established in 1902 initially as the Japanese Society of Neurology under the management of the psychiatrist HidezoKure and the internist Kinnosuke Miura with a membership of about 200. The journal of the society, the Neurologia Japonica, was published in the same year. The Fellowship Award is presented to early-career psychiatrists from Asia and around the world. The purpose of the Award is to recognize early-career, outstanding psychiatrists and to encourage academic discussion and personal friendships with early-career Japanese psychiatrists at the 114th Annual Meeting of the JSPN.

Inscrições:
até dia 20 de outubro de 2017.

Mais informações no site.

Objetivo:
Estimular jovens estudantes com vocação para a pesquisa científica e o desenvolvimento tecnológico. Os estudantes selecionados serão orientados, de modo individualizado, por um pesquisador e/ou tecnólogo qualificado de um dos Laboratórios Nacionais do CNPEM. A missão do estudante e desenvolver um projeto proposto pelo orientador e apresentar resultados em formas de comunicação oral (seminários), comunicação escrita resumida e comunicação escrita em forma de relatório final de pesquisa.

Inscrições:
até dia 18 de outubro de 2017.

Mais informações no site.

Objetivo:
The Newton Mobility Grants aims to help strengthen the research and innovation capacity of researchers from partner countries by assisting them in visiting or sending staff and students to the UK and developing networks, research projects and partnerships with their UK hosts/counterparts and the wider UK research and innovation community. The scheme is designed to offer a flexible platform for early career and established group leaders in partner countries to interact with their UK counterparts.

Inscrições:
até dia 10 de outubro de 2017.

Mais informações no site.

Objetivo:
Reconhecer e premiar trabalhos que, de forma inovadora, melhorem a qualidade de vida das populações em desenvolvimento.

Inscrições:
até dia 26 de setembro de 2017.

Mais informações no site.

Objetivo:
The NPF provides Grants to projects which fall into one of the following areas: Charity, Educational, Environmental conservation, Medical research, Construction, Cultural/Artistic. The categories “Campaigns” and “Historical Partners” include projects which are grouped according to various criteria. The Nando and Peretti Foundation is a non-profit foundation. Therefore, the candidate must be a non-profit organization (association, foundation, cultural association, university, academic institution, etc.).

Inscrições:
October 31 through November 17, 2017.

Mais informações no site.

Objetivo:
The Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) Therapeutics Development Award (TDA) program is designed to stimulate businesses to pursue novel therapies for cystic fibrosis by filling the gap between basic research and Phase 3 clinical trials. The program provides companies with funding and other resources to support studies that may include drug discovery, pre-clinical safety, PK/PD, and ADME testing through early safety and efficacy trials in patients.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption, the epidemiology and etiology, including genetics, of alcohol-related problems. Research grants for the Secondary Analyses of Existing Alcohol Research Data are intended to provide support for studies that utilize currently available data sets to increase our understanding of the incidence, prevalence and etiology of alcohol related problems and disorders in the population, as well as the risk and protective factors associated with them.

Inscrições:
R01: October 05, 2017;
R03: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2020.

Mais informações em R01 e R03.

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

Inscrições:
R21/R33: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

Inscrições:
R01: October 05, 2017;
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações em R01 e R21.